The final decision from Editorial Office on acceptance or rejection for publication is forwarded to the corresponding author from the Editorial Office. All the process is conducted in double-blind fashion, which means the reviewer do not know the identity of the authors, and vice versa. The decision letters from the reviewer(s) are sent to the Editorial Office, and the Editorial Office forwards the decision letter with reviewed manuscripts to the corresponding author. A reviewer may recommend 'accept,' 'accept with minor revision,' 'reject but resubmission possible,' or 'reject.' If there is a marked discrepancy in the decisions between two reviewers or between the opinions of the author and the reviewer(s), the editor may send the manuscript to 3 rd reviewer for additional comments and a recommended decision. Acceptance of the manuscript is decided on the basis of the critiques and recommended decision of the reviewers. Ann Dermatol adopts double-blind review, which means that the reviewers and authors cannot identify each others’ information.

Peer reviewers are selected from the Board’s specialist database. If the manuscript is considered valuable and appropriate for the journal, then the Editor-in-Chief assigns the 2 most relevant investigators available for review of the contents. The manuscript which satisfies the basic structural format is sent to Editor-in-Chief for evaluating academic relevancy. If the structure of the manuscript is not sufficient for the instructions in Authors’ guideline, then the manuscript will not accepted. The Editorial Office of Ann Dermatol reviews all manuscripts received and a manuscript is previewed for its format.

Clinical trials endnote free trial